QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
Log in

NASDAQ:STAASTAAR Surgical Stock Price, Forecast & News

$49.69
-1.73 (-3.36 %)
(As of 08/11/2020 12:44 PM ET)
Add
Compare
Today's Range
$46.46
Now: $49.69
$50.01
50-Day Range
$51.42
MA: $57.85
$61.81
52-Week Range
$23.20
Now: $49.69
$62.51
Volume75,385 shs
Average Volume629,326 shs
Market Capitalization$2.28 billion
P/E Ratio310.58
Dividend YieldN/A
Beta1.63
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.
Read More
STAAR Surgical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.68 out of 5 stars


Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.18 million
Cash Flow$0.52 per share
Book Value$3.59 per share

Profitability

Net Income$14.05 million

Miscellaneous

Employees475
Market Cap$2.28 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$49.69
-1.73 (-3.36 %)
(As of 08/11/2020 12:44 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

How has STAAR Surgical's stock price been impacted by COVID-19?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, STAA shares have increased by 76.4% and is now trading at $49.40.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of STAAR Surgical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for STAAR Surgical
.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for STAAR Surgical
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its earnings results on Wednesday, August, 5th. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.01. The medical instruments supplier earned $35.19 million during the quarter, compared to analysts' expectations of $37.60 million. STAAR Surgical had a net margin of 5.03% and a return on equity of 9.01%. During the same quarter in the previous year, the company posted $0.08 EPS.
View STAAR Surgical's earnings history
.

What price target have analysts set for STAA?

6 equities research analysts have issued 1 year price targets for STAAR Surgical's stock. Their forecasts range from $41.00 to $70.00. On average, they anticipate STAAR Surgical's stock price to reach $58.83 in the next year. This suggests a possible upside of 19.1% from the stock's current price.
View analysts' price targets for STAAR Surgical
.

Has STAAR Surgical been receiving favorable news coverage?

Media stories about STAA stock have been trending neutral recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. STAAR Surgical earned a news impact score of 0.2 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about STAAR Surgical
.

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include NVIDIA (NVDA), Crowdstrike (CRWD), Shopify (SHOP), Livongo Health (LVGO), Paypal (PYPL), Walt Disney (DIS), AbbVie (ABBV), Docusign (DOCU), Netflix (NFLX) and Teladoc Health (TDOC).

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 65)
  • Ms. Deborah J. Andrews, Chief Financial Officer (Age 62)
  • Dr. Keith Holliday, Chief Technology Officer (Age 56)
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 57)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations, Direct Markets- Europe & China (Age 54)

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include TimesSquare Capital Management LLC (1.35%), Defender Capital LLC. (1.22%), Principal Financial Group Inc. (0.83%), KAMES CAPITAL plc (0.68%), Ziegler Capital Management LLC (0.50%) and Kornitzer Capital Management Inc. KS (0.36%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, Jon K Hayashida, Keith Holliday, Samuel J Gesten, Scott D Barnes and William P Wall.
View institutional ownership trends for STAAR Surgical
.

Which institutional investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Defender Capital LLC., SG Americas Securities LLC, Spouting Rock Asset Management LLC, Matthews International Capital Management LLC, Dfpg Investments LLC, Roubaix Capital LLC, and Kornitzer Capital Management Inc. KS. Company insiders that have sold STAAR Surgical company stock in the last year include Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, Jon K Hayashida, Keith Holliday, Samuel J Gesten, and Scott D Barnes.
View insider buying and selling activity for STAAR Surgical
.

Which institutional investors are buying STAAR Surgical stock?

STAA stock was acquired by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Ziegler Capital Management LLC, Calamos Advisors LLC, WINTON GROUP Ltd, Russell Investments Group Ltd., KAMES CAPITAL plc, Mutual of America Capital Management LLC, and Virtu Financial LLC.
View insider buying and selling activity for STAAR Surgical
.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $49.40.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $2.26 billion and generates $150.18 million in revenue each year. The medical instruments supplier earns $14.05 million in net income (profit) each year or $0.46 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.